A restrictive threshold for red-cell transfusion is noninferior to a liberal threshold for patients undergoing cardiac surgery.
No evidence shows efficacy of PCI procedures for patients with stable coronary artery disease with angina.
Percutaneous coronary intervention does not increase exercise time more than a placebo procedure in patients with angina and severe coronary stenosis.
Alternative antiplatelet therapy after percutaneous coronary intervention in patients with a CYP2C19 loss-of-function allele may have lower risk of MACE compared to clopidogrel.
Percutaneous coronary intervention of the culprit lesion is associated with better 30-day outcomes than immediate multivessel PCI in patients with patients with multivessel CAD and acute MI.
Patients who received bioresorbable vascular scaffolds had higher rates of device thrombosis and target vessel MI compared with those who received everolimus-eluting stents.
Researchers analyzed 3-year outcomes in patients implanted with bioresorbable vascular scaffolds for the treatment of coronary lesions.
A substudy analyzed whether PCI outcomes using second generation drug eluting stents were comparable to CABG in patients with low or intermediated complexity left main coronary artery disease.
Perioperative myocardial injury occurs more with morning surgery than with afternoon surgery in patients undergoing aortic valve replacement.
Patients with atrial fibrillation had improved late survival when treated with ablation-assisted Cox-Maze IV and cardiac surgery.
Change in inducibility status after pulmonary vein isolation is not associated with long-term freedom from recurrent arrhythmia.
The FDA approved the Confirm Rx insertable cardiac monitor, which is implanted under the skin in a minimally-invasive outpatient procedure.
Women and minorities undergoing PCI with everolimus-eluting stents have a risk of MACE similar to that of white men.
Patients with heart failure who received transcatheter aortic valve replacements saw decrease in aortic valve mean gradient.
Everolimus-eluting bioresorbable vascular scaffolds are associated with increased odds of scaffold thrombosis and other thrombotic events.
Appropriate use criteria have been developed for the treatment of patients with severe aortic stenosis.
Serum albumin can predict transcatheter aortic valve replacement-related mortality.
A first-line contact aspiration technique demonstrates no significant benefit over the stent retriever technique in achieving revascularization in patients with acute ischemic stroke.
Medicare paid at least $1.5 billion over a decade to replace 7 types of defective heart devices that apparently failed.
No screening necessary for an asymptomatic patient with cardiovascular risk and stenosis of 50% on screening carotid ultrasonography.
Postmarketing adverse events related to the CardioMEMS HF System are infrequent, but can be serious.
Ablating non-PV triggers is associated with improved outcomes in patients with atrial fibrillation with 2 or more failed PVI procedures.
Vitamin D did not produce a substantial preventive effect on cardiac injury during percutaneous coronary intervention.
Patients with atrial fibrillation who are at a low risk for stroke do not receive a major benefit from long-term aspirin therapy.
Pulmonary endarterectomy is an effective treatment for patients with chronic thromboembolic pulmonary hypertension.
For patients with atrial fibrillation who undergo percutaneous coronary intervention, the risk of bleeding is lower with dual therapy vs triple therapy.
In patients undergoing percutaneous coronary intervention for either STEMI or NSTEMI, bivalirudin and heparin produce similar outcomes.
Coronary artery bypass grafting yielded better outcomes in patients with type 1 diabetes who had multivessel disease compared with percutaneous coronary intervention.
Coronary-artery bypass grafting patients were found to live longer if their surgeons performed the operation with cardiopulmonary bypass.
For patients undergoing cardiac surgery, increasing obesity is associated with increased intensive care unit resource utilization.
The Cardiology Advisor Articles
- Continuous Furosemide Infusion Superior to Bolus Furosemide in Heart Failure
- ACC/AHA Release 2017 Quality Measures for STEMI/NSTEMI Management
- Role of Coffee Consumption in Heart Failure, Stroke Outcomes
- Atrial Fibrillation Survival Better With Cardiac Surgery, Cox-Maze IV
- Borderline Pulmonary Hypertension Commonly Found During Right Heart Catheterization
- Heart Failure Related to Methamphetamine Use: Possible New Epidemic?
- Cardiac Surgery: Restrictive vs Liberal Threshold for Red-Cell Transfusion
- High-Sensitivity Cardiac Troponin I Threshold Identifies Patients at Low Risk for MI, Death
- Hospital Readmissions Reduction Program Decreases Heart Failure Readmissions
- Canakinumab May Lower Lung Cancer Incidence in Patients With Atherosclerosis